Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2018-05-16 Director's Dealing
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 3 pages 49.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details a change in the relevant interests of a company director, specifically the sale of shares by Mr. Maurie Stang, a Non-Executive Chairman. It includes specifics about the number of shares held before and after the transaction, the nature of the interest, and the date of the change. The document references ASX listing rules and the Corporations Act, indicating it is a regulatory filing related to insider share transactions by a director. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document is not an announcement of a report, nor is it a full financial report or management information. Therefore, the correct classification is DIRS (Director's Dealing). The document length and detail support a high confidence in this classification.
2018-05-16 English
Nanosonics receives Health Canada clearance for trophon2 1
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 4 May 2018 from Nanosonics Limited, reporting receipt of Health Canada clearance for their medical device trophon2. It references a prior announcement about US FDA clearance and discusses market launch plans. The content is a regulatory update about product approval and market entry, not a financial report, earnings release, or management discussion. The document is short (2131 characters) and serves as a news announcement rather than a detailed report or presentation. It does not contain financial data, voting results, or legal proceedings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance updates that do not fit other specific categories.
2018-05-03 English
Ceasing to be a substantial holder from MQG 18 pages 646.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001 Section 671B. It details changes in substantial shareholding interests, including dates, entities involved, and associated controlled bodies corporate. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes.
2018-05-03 English
Becoming a substantial holder from MQG 24 pages 624.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001 Section 671B. It details the substantial shareholding of Macquarie Group Limited in Nanosonics Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding or change in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure of shareholding. The length and content confirm it is the actual notification, not just an announcement or certification.
2018-05-02 English
Change in substantial holding 4 pages 62.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 under the Corporations Act 2001 Section 671B, titled 'Notice of Change of Interests of Substantial Holder'. It details changes in voting power and shareholdings of a substantial holder (FMR LLC) in NANOSONICS LTD, including dates and quantities of share purchases and sales. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is about shareholding changes, not an annual report, earnings release, or other financial report. Therefore, the correct classification is MRQ with high confidence.
2018-04-30 English
Nanosonics receives FDA clearance for trophon2 2 pages 147.9KB
Regulatory Filings Classification · 95% confidence The document is a company announcement from Nanosonics dated 27 April 2018, reporting the receipt of FDA clearance for a new medical device (trophon2). It discusses product features, regulatory approvals, market plans, and expected commercial release. There are no financial statements, earnings data, or detailed financial analysis. The content is an update on regulatory approval and product launch rather than a financial report or management discussion. It is not a report publication announcement since it contains substantive information about the product and regulatory status. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance updates that do not fit other categories.
2018-04-26 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.